Osborne Clarke advises LAVA Therapeutics on $83 million Series C financing
Osborne Clarke advises LAVA Therapeutics on $83 million Series C financing. Osborne Clarke in Amsterdam has advised LAVA Therapeutics, a...
Published on
17/09/2020
Read time
1m